Ping An Biomedical Co., Ltd. (MJID)

Ping An Biomedical Income Statement

Financials in millions CNY. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	87.62	82.56	114.55	99.52	55.46
Revenue Growth (YoY)	6.13%	-27.92%	15.10%	79.43%	-
Cost of Revenue	82.21	78.32	100.4	85.25	44.8
Gross Profit	5.42	4.24	14.14	14.27	10.67
Selling, General & Admin	5.3	3.6	3.52	3.76	3.05
Operating Expenses	5.42	3.63	3.33	6	6.21
Operating Income	-0	0.61	10.82	8.27	4.46
Interest Expense	-0.71	-1.74	-1.57	-1.36	-1.04
Interest & Investment Income	0	0.16	0.04	0	0.01
Currency Exchange Gain (Loss)	-0.01	0.21	-0	0.19	0.05
Other Non Operating Income (Expenses)	0.03	0.8	0.34	0.72	0
Pretax Income	-0.68	0.04	9.63	7.82	3.48
Income Tax Expense	0.6	1.04	2.4	2.61	1.55
Net Income	-1.28	-0.99	7.23	5.21	1.92
Net Income to Common	-1.28	-0.99	7.23	5.21	1.92
Net Income Growth	-	-	38.61%	170.96%	-
Shares Outstanding (Basic)	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18
EPS (Basic)	-0.07	-0.06	0.40	0.29	0.11
EPS (Diluted)	-0.07	-0.06	0.40	0.29	0.11
EPS Growth	-	-	38.61%	170.96%	-
Free Cash Flow	14.63	-6.08	21.06	-31.4	-7.18
Free Cash Flow Per Share	0.81	-0.34	1.17	-1.74	-0.40
Gross Margin	6.18%	5.14%	12.35%	14.34%	19.23%
Operating Margin	-0.00%	0.74%	9.44%	8.31%	8.04%
Profit Margin	-1.47%	-1.20%	6.31%	5.24%	3.47%
Free Cash Flow Margin	16.70%	-7.37%	18.39%	-31.55%	-12.95%
EBITDA	0.01	0.65	10.84	8.29	4.46
EBITDA Margin	0.01%	0.78%	9.46%	8.33%	8.05%
D&A For EBITDA	0.01	0.03	0.02	0.02	0
EBIT	-0	0.61	10.82	8.27	4.46
EBIT Margin	-0.00%	0.74%	9.44%	8.31%	8.04%
Effective Tax Rate	-	2484.34%	24.92%	33.32%	44.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q